Interventional cardiology is branch of cardiology that deals with catheter based treatment of cardiovascular diseases. Interventional cardiology uses small flexible tube known as catheter to repair damaged or narrowed heart arteries or other affected parts of heart structure. A large number of heart problems can be rectified by using cardiovascular catheterization. The most commonly used treatment for cardiovascular diseases involve insertion of sheath into artery and cannulising the heart under x-ray visualization. Cannulising heart vessels offers several benefits such as easy accessibility of artery, better control on bleeding during procedure and enhancement of convenience and comfort delivered to patients. Angioplasty and stenting are common types of interventional techniques used to correct heart deformities.
Common conditions which can be effectively treated with interventional cardiology include coronary artery diseases, heart wall diseases and peripheral vascular diseases. Peripheral vascular diseases (PVD) are blood circulation disorder that causes blood vessels outside heart and brain to narrow or block due to arteriosclerosis leading to clot development. It is characterized by reduced weak pulses, cramps and heaviness in muscles. PVD can be treated with medication such as atorvastatin that increases blood flow to arteries and veins. Significant blockage requires high end surgeries such as angioplasty or vascular surgeries performed by inserting catheters in the artery of neck or arm and then threaded it to heart through blood vessels for improved blood circulation.
Increasing geriatric population, rise in demand for minimal invasive surgeries coupled with technological advancements are expected to drive growth of the market. According to a study conducted by American Heart Association in 2017, around 92.1 million American adults are living with some or other type of cardiovascular condition. Such high prevalence of cardiovascular diseases will increase demand for interventional cardiology devices. Furthermore, rise in patient awareness about coronary heart diseases and increasing demand for better healthcare infrastructure especially in emerging economies will propel growth of the market. However, high cost of devices and strict approval process for interventional devices is expected to slow down growth of the market.
Request for an in-depth table of contents for this report @ https://www.crystalmarketresearch.com/request-toc/upcoming/HC06107
Key players operating in the global market include Edwards Lifesciences Corporation, AngioDynamics, Inc., Becton, Dickinson and Company, Abbott Laboratories, Terumo Corporation, Cardinal Health, Inc., and Spectranetics Corporation. New product development is the key strategy adopted by many players operating in this industry to gain competitive edge by acquiring large market coverage. For instance in July 2016, Abbott had announced FDA approval for new product known as Absorb. Absorb is bioresorbable heart stent used for treating coronary heart disease. Absorb is only the treatment approved for treating coronary heart disease by keeping artery open which promotes healing of treated artery.
Emerging markets and technological advancements will provide ample growth opportunities for players operating in the global market. Furthermore, increasing FDA approval for new technologies and devices will drive the growth market in coming years. For instance in October 2012, FDA had approved robotic system for use in interventional cardiology procedures and for catheter ablations for precise controlled over cardiovascular diseases. In addition, development of Nanobots (small size robots) that might have application for targeted medical therapies in the future will revolutionize interventional cardiology and vascular peripheral devices market in coming years.
Make an inquiry @ https://www.crystalmarketresearch.com/send-an-enquiry/HC06107
About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
Toll Free: +1-888-213-4282